June 5, 2018 — The U.S. Food and Drug Administration (FDA) has cleared the Biograph Vision, a new positron emission ...
June 1, 2018 – Use of the Abbott Portico transcatheter aortic valve replacement (TAVR) therapy was associated with ...
May 31, 2018 – ReCor Medical announced that the RADIANCE-HTN SOLO study met its primary efficacy endpoint and ...
May 31, 2018 – Late-breaking trial results presented at the EuroPCR Congress, May 21-24 in Paris, France, found the ...
May 31, 2018 — Two-year outcome data from the BIO-RESORT randomized controlled trial were presented in a late-breaking ...
May 31, 2018 — The results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia ...
May 30, 2018 — Despite the best efforts of clinicians to manage hypertension, it continues to increase and is now ...
May 30, 2018 — Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy ...
May 29, 2018 – Investigators recently unveiled clinical data from the independently run Onyx 1-Month OCT Study showing ...
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable ...
May 29, 2018 — The first placebo-controlled trial that looked at how fractional flow reserve (FFR) and instantaneous ...
Here are the late-breaking trials and other key study presentations from the 2018 EuroPCR conference. This is the annual ...
May 25, 2018 — Data from the first-in-human study using pulsed electric field (PEF) energy ablate heart tissue in the ...
May 25, 2018 — Abbott announced favorable outcomes from the first 100 patients treated in a global study of its Tendyne ...
May 25, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for Xience Sierra ...
June 05, 2018